February 4, 2020
First-of-its-kind hydrogel platform enables on-demand production of medicines and chemicals
A 3D-printed hydrogel lattice.University of Texas
A team of chemical engineers has developed a new way to produce medicines and chemicals and preserve them using portable “biofactories” embedded in water-based gels known as hydrogels. The approach could help people in remote villages or on military missions, where the absence of pharmacies, doctor’s offices or even basic refrigeration makes it hard to access critical medicines and other small-molecule compounds.
The team — led by Hal Alper, a professor of chemical engineering at the University of Texas, and Alshakim Nelson, an assistant professor of chemistry at the University of Washington — describes the new approach in a paper published Feb. 4 in Nature Communications.
“We expect these developments to afford new technologies for on-demand production of small-molecule and peptide products in the future,” said Nelson, who is also a faculty member in the UW Molecular Engineering & Sciences Institute, in a commentary accompanying the paper. “This technology will be especially applicable in remote or isolated areas where space and resources are limited, which could include manned space missions or personalized medications.”
Their system effectively embeds microbial biofactories — cells engineered to overproduce a product — into the solid scaffold of a hydrogel, allowing for portability and optimized production. It is the first hydrogel-based system to organize both individual microbes and consortia for in-the-moment production of high-value chemical feedstocks, used for processes such as fuel and pharmaceutical production. Products can be produced within a couple of hours to a couple of days.
“Many of the chemicals, fuels, nutraceuticals and pharmaceuticals we use rely on traditional fermentation technology,” said Alper. “Our technology addresses a strong limitation in the fields of synthetic biology and bioprocessing, namely the ability to provide a means for both on-demand and repeated-use production of chemicals and antibiotics from both mono- and co-cultures.”
As a crosslinked polymer, the hydrogel used in this work can be 3D printed or manually extruded. The gel material, along with the cells inside, can flow like a liquid and then harden upon exposure to UV light. The resulting polymer network is large enough for molecules and proteins to move through it, but the space is too small for cells to leak out.
The team also found that by freeze-drying the hydrogel system, it can effectively preserve the fermentation capacity of the biofactories until needed in the future. The result of the freeze-drying somewhat resembles an ancient mummy, shriveled up but well-preserved. To revive the hydrogel, the researchers simply added water, sugar and other basic nutrients, and the cells could resume production just as effectively as before the preservation process.
One of the novel applications enabled by this platform is the ability to combine multiple different organisms, called consortia, together in a way that outperforms traditional, large-scale bioreactors. In particular, this system enables a plug-and-play approach to combining and optimizing chemical production. For example, if one set of enzymes works best in the bacteria E. coli, while the other works best in budding yeast, the two organisms can work together to more efficiently go straight to the product. The research team tested both of these organisms.
This platform has the added benefit of multitasking, keeping different types of cells separated while they grow, preventing one from taking over and killing off the others. Likewise, by testing a range of temperatures, the team could control the dynamics of the system, keeping the growth of multiple cell types balanced.
Finally, the team showed continuous, repeated use of the system — with yeast cells — over the course of an entire year without a decrease in yields, indicating the sustainability of the process over time.
Medicines such as antibiotics have a fixed shelf life and require specific storage conditions. The portability of a biofactory that can synthesize these molecules makes the hydrogel system especially useful in remote places that don’t have access to refrigeration to store medications. It would also be a small and compact way to maintain access to several medications and other essential chemicals when there is no access to a pharmacy or a store, like during a military mission or a mission to Mars. Although not quite there yet, the possibilities are promising.
“This technology can be applied to a wide range of products and cell types. We see engineers and scientists being able to plug and play with different consortia of cells to produce diverse products that are needed for a specific scenario,” Alper said. “That’s part of what makes this technology so exciting.”
Co-lead authors on the paper are UW graduate student Trevor Johnston and University of Texas graduate student Shuo-Fu Yuan. Co-authors are James Wagner and Xiunan Yi at the University of Texas, former UW postdoctoral researcher Abhijit Saha, and UW graduate student Patrick Smith. The research was funded by the Camille and Henry Dreyfus Foundation, the University of Washington and the Royalty Research Fund.
For more information contact Nelson at alshakim@uw.edu.
Adapted from a press release by the University of Texas news office.
Tag(s): Alshakim Nelson • cell biology • College of Arts & Sciences • Department of Chemistry • microbes and viruses • Molecular Engineering & Sciences Institute • population health
